214 related articles for article (PubMed ID: 11051237)
1. P73 gene expression in ovarian cancer tissues and cell lines.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Oct; 6(10):3910-5. PubMed ID: 11051237
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
[TBL] [Abstract][Full Text] [Related]
3. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
[TBL] [Abstract][Full Text] [Related]
4. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
5. Analysis of p73 in human borderline and invasive ovarian tumor.
Ng SW; Yiu GK; Liu Y; Huang LW; Palnati M; Jun SH; Berkowitz RS; Mok SC
Oncogene; 2000 Apr; 19(15):1885-90. PubMed ID: 10773878
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours.
Zwahlen D; Tschan MP; Grob TJ; Peters UR; Fink D; Haenggi W; Altermatt HJ; Cajot JF; Tobler A; Fey MF; Aebi S
Int J Cancer; 2000 Oct; 88(1):66-70. PubMed ID: 10962441
[TBL] [Abstract][Full Text] [Related]
8. Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer.
Chi SG; Chang SG; Lee SJ; Lee CH; Kim JI; Park JH
Cancer Res; 1999 Jun; 59(12):2791-3. PubMed ID: 10383132
[TBL] [Abstract][Full Text] [Related]
9. Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas.
Martinez-Delgado B; Melendez B; Cuadros M; Jose Garcia M; Nomdedeu J; Rivas C; Fernandez-Piqueras J; BenÃtez J
Int J Cancer; 2002 Nov; 102(1):15-9. PubMed ID: 12353228
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the wild type p73 gene in human bladder cancer.
Yokomizo A; Mai M; Tindall DJ; Cheng L; Bostwick DG; Naito S; Smith DI; Liu W
Oncogene; 1999 Feb; 18(8):1629-33. PubMed ID: 10102633
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target.
Imyanitov EN; Birrell GW; Filippovich I; Sorokina N; Arnold J; Mould MA; Wright K; Walsh M; Mok SC; Lavin MF; Chenevix-Trench G; Khanna KK
Oncogene; 1999 Aug; 18(32):4640-2. PubMed ID: 10467409
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.
Corn PG; Kuerbitz SJ; van Noesel MM; Esteller M; Compitello N; Baylin SB; Herman JG
Cancer Res; 1999 Jul; 59(14):3352-6. PubMed ID: 10416592
[TBL] [Abstract][Full Text] [Related]
13. Loss of p73 expression in six non-small cell lung cancer cell lines is associated with 5'CpG island methylation.
Liu K; Zhan M; Zheng P
Exp Mol Pathol; 2008 Feb; 84(1):59-63. PubMed ID: 18022156
[TBL] [Abstract][Full Text] [Related]
14. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity.
Araki D; Uzawa K; Watanabe T; Shiiba M; Miyakawa A; Yokoe H; Tanzawa H
Int J Oncol; 2002 Feb; 20(2):355-60. PubMed ID: 11788901
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
Zaika AI; Kovalev S; Marchenko ND; Moll UM
Cancer Res; 1999 Jul; 59(13):3257-63. PubMed ID: 10397274
[TBL] [Abstract][Full Text] [Related]
16. Overexpression but lack of mutation and methylation of p73 in hepatocellular carcinoma.
Pan H; Liao SJ; Lai WY; Lu HC; Hsiao KM
Acta Oncol; 2002; 41(6):550-5. PubMed ID: 12546528
[TBL] [Abstract][Full Text] [Related]
17. Allelic expression of the putative tumor suppressor gene p73 in human fetal tissues and tumor specimens.
Hu JF; Ulaner GA; Oruganti H; Ivaturi RD; Balagura KA; Pham J; Vu TH; Hoffman AR
Biochim Biophys Acta; 2000 Apr; 1491(1-3):49-56. PubMed ID: 10760569
[TBL] [Abstract][Full Text] [Related]
18. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma.
Kang MJ; Park BJ; Byun DS; Park JI; Kim HJ; Park JH; Chi SG
Clin Cancer Res; 2000 May; 6(5):1767-71. PubMed ID: 10815895
[TBL] [Abstract][Full Text] [Related]
19. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
[TBL] [Abstract][Full Text] [Related]
20. Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion.
Barbolina MV; Adley BP; Shea LD; Stack MS
Cancer; 2008 Apr; 112(7):1632-41. PubMed ID: 18260155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]